For: | Sollelis E, Quinard RM, Bouguen G, Goutte M, Goutorbe F, Bouvier D, Pereira B, Bommelaer G, Buisson A. Combined evaluation of biomarkers as predictor of maintained remission in Crohn’s disease. World J Gastroenterol 2019; 25(19): 2354-2364 [PMID: 31148906 DOI: 10.3748/wjg.v25.i19.2354] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v25/i19/2354.htm |
Number | Citing Articles |
1 |
Jin-Tong Shi, Nuo Chen, Jia Xu, Hemant Goyal, Zhi-Qi Wu, Jie-Xin Zhang, Hua-Guo Xu. Diagnostic Accuracy of Fecal Calprotectin for Predicting Relapse in Inflammatory Bowel Disease: A Meta-Analysis. Journal of Clinical Medicine 2023; 12(3): 1206 doi: 10.3390/jcm12031206
|
2 |
Steve Halligan, Darren Boone, Lucinda Archer, Tariq Ahmad, Stuart Bloom, Manuel Rodriguez-Justo, Stuart A Taylor, Sue Mallett. Prognostic biomarkers to identify patients likely to develop severe Crohn’s disease: a systematic review. Health Technology Assessment 2021; 25(45): 1 doi: 10.3310/hta25450
|
3 |
Dan Turner, Amanda Ricciuto, Ayanna Lewis, Ferdinando D’Amico, Jasbir Dhaliwal, Anne M. Griffiths, Dominik Bettenworth, William J. Sandborn, Bruce E. Sands, Walter Reinisch, Jürgen Schölmerich, Willem Bemelman, Silvio Danese, Jean Yves Mary, David Rubin, Jean-Frederic Colombel, Laurent Peyrin-Biroulet, Iris Dotan, Maria T. Abreu, Axel Dignass. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology 2021; 160(5): 1570 doi: 10.1053/j.gastro.2020.12.031
|
4 |
Jennie Clough, Michael Colwill, Andrew Poullis, Richard Pollok, Kamal Patel, Sailish Honap. Biomarkers in inflammatory bowel disease: a practical guide. Therapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241251600
|
5 |
Nikolas Plevris, Charlie W. Lees. Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities. Gastroenterology 2022; 162(5): 1456 doi: 10.1053/j.gastro.2022.01.024
|
6 |
T. Kucharzik, B. Verstockt, C. Maaser. Monitoring of patients with active inflammatory bowel disease. Frontiers in Gastroenterology 2023; 2 doi: 10.3389/fgstr.2023.1172318
|
7 |
Lorant Gonczi, Talat Bessissow, Peter Laszlo Lakatos. Disease monitoring strategies in inflammatory bowel diseases: What do we mean by “tight control”?. World Journal of Gastroenterology 2019; 25(41): 6172-6189 doi: 10.3748/wjg.v25.i41.6172
|
8 |
Kohei Wagatsuma, Yoshihiro Yokoyama, Hiroshi Nakase. Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease. Life 2021; 11(12): 1375 doi: 10.3390/life11121375
|
9 |
Gabriele Dragoni, Tommaso Innocenti, Andrea Galli. Biomarkers of Inflammation in Inflammatory Bowel Disease: How Long before Abandoning Single-Marker Approaches?. Digestive Diseases 2021; 39(3): 190 doi: 10.1159/000511641
|
10 |
David Huynh, Denis Rubtsov, Debapama Basu, Myat Myat Khaing. The Diagnostic Utility of Biochemical Markers and Intestinal Ultrasound Compared with Endoscopy in Patients with Crohn’s Disease and Ulcerative Colitis: A Systemic Review and Meta-Analysis. Journal of Clinical Medicine 2024; 13(11): 3030 doi: 10.3390/jcm13113030
|
11 |
Changchang Ge, Zhaofeng Shen, Yi Lu, Xiaojuan Liu, Yiheng Tong, Mengyuan Zhang, Yijing Liu, Hong Shen, Lei Zhu. Propensity score analysis the clinical characteristics of active distal and extensive ulcerative colitis: a retrospective study. Frontiers in Physiology 2023; 14 doi: 10.3389/fphys.2023.1136659
|
12 |
Changchang Ge, Yi Lu, Hong Shen, Lei Zhu. Monitoring of intestinal inflammation and prediction of recurrence in ulcerative colitis. Scandinavian Journal of Gastroenterology 2022; 57(5): 513 doi: 10.1080/00365521.2021.2022193
|
13 |
Eleni Orfanoudaki, Kalliopi Foteinogiannopoulou, Eirini Theodoraki, Ioannis E. Koutroubakis. Recent Advances in the Optimization of Anti-TNF Treatment in Patients with Inflammatory Bowel Disease. Journal of Clinical Medicine 2023; 12(7): 2452 doi: 10.3390/jcm12072452
|
14 |
Elena Ricart, Guillermo Bastida, Daniel Carpio, Daniel Ceballos, Daniel Ginard, Ignacio Marín-Jimenéz, Luis Menchén, Fernando Muñoz, Yago González-Lama. Clinical Approach to STRIDE-II in Real-Life Settings: Analysis and Practical Recommendations. Crohn's & Colitis 360 2024; 6(4) doi: 10.1093/crocol/otae055
|
15 |
Maté Gergely, Parakkal Deepak. Tools for the Diagnosis and Management of Crohn's Disease. Gastroenterology Clinics of North America 2022; 51(2): 213 doi: 10.1016/j.gtc.2021.12.003
|